Artiva Biotherapeutics halts cell therapy and lays off staff after patient deaths 94%, falls in pre-market trading 30%
BlockBeats, citing BIT stock platform data, stated that Artiva Biotherapeutics halted cell therapy and laid off staff after the deaths of patients 94%, falling in pre-market trading 30%。